Trial · NCT02998151
Results by group25
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 25
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in EEG Relative Gamma Power | Placebo | 0.0024 | Standard Deviation .0265 | percent of power in gamma frequencies | |
| Change in EEG Relative Gamma Power | Acamprosate | -0.0077 | Standard Deviation 0.0252 | percent of power in gamma frequencies | |
| Change in EEG Relative Gamma Power | Lovastatin | -0.0039 | Standard Deviation 0.0225 | percent of power in gamma frequencies | |
| Change in EEG Relative Gamma Power | Minocycline | 0.0019 | Standard Deviation 0.0235 | percent of power in gamma frequencies | |
| Change in EEG Relative Gamma Power | Baclofen | -0.0160 | Standard Deviation 0.0346 | percent of power in gamma frequencies | |
| Clinical Global Impressions-Improvement | Placebo | 3.70 | Standard Deviation .61 | score on a scale | |
| Clinical Global Impressions-Improvement | Acamprosate | 3.88 | Standard Deviation .62 | score on a scale | |
| Clinical Global Impressions-Improvement | Lovastatin | 3.97 | Standard Deviation .50 | score on a scale | |
| Clinical Global Impressions-Improvement | Minocycline | 3.81 | Standard Deviation .49 | score on a scale | |
| Clinical Global Impressions-Improvement | Baclofen | 3.94 | Standard Deviation .43 | score on a scale | |
| Woodcock Johnson Test of Cognitive Abilities - Auditory Attention Task | Placebo | 32.84 | Standard Deviation 5.77 | score on a scale | |
| Woodcock Johnson Test of Cognitive Abilities - Auditory Attention Task | Acamprosate | 33.07 | Standard Deviation 5.48 | score on a scale | |
| Woodcock Johnson Test of Cognitive Abilities - Auditory Attention Task | Lovastatin | 32.93 | Standard Deviation 5.31 | score on a scale | |
| Woodcock Johnson Test of Cognitive Abilities - Auditory Attention Task | Minocycline | 33.24 | Standard Deviation 6.04 | score on a scale | |
| Woodcock Johnson Test of Cognitive Abilities - Auditory Attention Task | Baclofen | 33 | Standard Deviation 5.17 | score on a scale | |
| Change From Pre-dose in the Repeatable Battery for the Assessment of Neuropsychological Status at 4 Hours Post Dose | Placebo | -.20 | Standard Deviation 4.23 | number of words remembered | |
| Change From Pre-dose in the Repeatable Battery for the Assessment of Neuropsychological Status at 4 Hours Post Dose | Acamprosate | -1.47 | Standard Deviation 5.17 | number of words remembered | |
| Change From Pre-dose in the Repeatable Battery for the Assessment of Neuropsychological Status at 4 Hours Post Dose | Lovastatin | -1.25 | Standard Deviation 3.85 | number of words remembered | |
| Change From Pre-dose in the Repeatable Battery for the Assessment of Neuropsychological Status at 4 Hours Post Dose | Minocycline | -.69 | Standard Deviation 5.58 | number of words remembered | |
| Change From Pre-dose in the Repeatable Battery for the Assessment of Neuropsychological Status at 4 Hours Post Dose | Baclofen | -.88 | Standard Deviation 3.35 | number of words remembered |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02998151/results